It has been demonstrated in 50 patients with a median HCC volume of 9 cm3 (range: 5–16 cm3) that there is an increase in prothrombotic hemostatic profile due to increased thrombomodulin and reduced activation of fibrinolysis compared to controls without HCC. This evidence concerns the gene THBD and hepatocellular carcinoma.